RP-14042

N/A

Report date: 2025/06/11 11:23:47
NME

Base Information

Drug NameRP-14042
Drug Alias NamePARP7 inhibitors (Rhizen Pharmaceuticals/Incozen therapeutics)RP-14055RP-14042
ClassificationSmall molecules
Mechanisms of ActionTCDD-inducible poly [ADP-ribose] polymerase inhibitorsCell cycle inhibitors
TargetsTCDD-inducible poly [ADP-ribose] polymerase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRhizen Pharmaceuticals Sa
China Registration ClassN/A

Develop Information

Active CompaniesIncozen Therapeutics Pvt LtdRhizen Pharmaceuticals Sa
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A